Cargando…
Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases
INTRODUCTION: Bone marrow derived cellular therapies are an emerging approach to promoting therapeutic angiogenesis in ischemic cardiovascular disease. However, the percentage of regenerative cells in bone marrow mononuclear cells (BMMNCs) is small, and large amounts of BMMNCs are required. Ixmyeloc...
Autores principales: | Ledford, Kelly J, Murphy, Nikki, Zeigler, Frank, Bartel, Ronnda L, Tubo, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413547/ https://www.ncbi.nlm.nih.gov/pubmed/25889271 http://dx.doi.org/10.1186/s13287-015-0007-3 |
Ejemplares similares
-
Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages
por: Ledford, Kelly J, et al.
Publicado: (2013) -
Potential beneficial effects of ixmyelocel-T in the treatment of atherosclerotic diseases
por: Ledford, Kelly J, et al.
Publicado: (2013) -
From Bench to Bedside: Review of Gene and Cell-Based Therapies and the Slow Advancement into Phase 3 Clinical Trials, with a Focus on Aastrom’s Ixmyelocel-T
por: Bartel, Ronnda L., et al.
Publicado: (2013) -
The Aastrom experience
por: Bartel, Ronnda L, et al.
Publicado: (2012) -
Editorial: Multicellularity in the Cardiovascular System
por: Madeddu, Paolo, et al.
Publicado: (2019)